Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Rilematovir

Generic Name: Rilematovir

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₀ClF_₃N_₄O_₃S

CAS Number: 1383450-81-4

Unique Ingredient Identifier: NQ99E8OH3P

Overview

Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)).

Background

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants

Phase 1

Completed

Posted: 2019/09/16

Sponsor:Janssen Research & D...

ID:NCT04090086

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Phase 2

Terminated

Posted: 2018/09/04

Sponsor:Janssen Research & D...

ID:NCT03656510

A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants

Phase 1

Completed

Posted: 2016/12/26

Sponsor:Janssen Research & D...

ID:NCT03002779

A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Concept Formulation Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of Oral Concept Formulation

Phase 1

Completed

Posted: 2016/10/26

Sponsor:Janssen Research & D...

ID:NCT02945007

A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adults

Phase 1

Completed

Posted: 2016/04/06

Sponsor:Janssen Research & D...

ID:NCT02729467

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy

Drug Development Updates

Rilematovir

Overview

Background

Indication

Associated Conditions

Clinical Trials

FDA Approved Products

Singapore Approved Products

Related News

RSV Treatment Landscape Expands with New Vaccines and Clinical Trials in 2024-2025

RSV Therapeutic Pipeline Shows Promise with Novel Therapies and Clinical Advancements

Drug Development Updates